Interestingly, many cases of miRNA targeting seem to be relevant particularly in those cancers for which AURKA overexpression is considered a promoting factor and a marker of poor prognosis, such as breast cancer, HCC and lung cancer. The gene discussed is AURKA; the disease is breast cancer.